The automated cell counter global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Automated Cell Counter Market, 2024report by The Business Research Company
offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size - The automated cell counter market size has grown strongly in
recent years. It will grow from $5.08 billion in 2023 to $5.42 billion in 2024
at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic
period can be attributed to increased awareness, advancements in diagnostic
techniques, environmental factors, antifungal resistance, population growth,
and immune compromised populations.
The automated cell counter market size is expected to see strong growth in the
next few years. It will grow to $7.02 billion in 2028 at a compound annual
growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed
to regulatory support, environmental concerns, antimicrobial resistance, an
aging population, precision medicine, global healthcare spending, infectious
disease outbreaks, research funding, accessibility, and affordability. Major
trends in the forecast period include regulatory support for innovation,
expansion of the biopharmaceutical sector, increasing research activities,
global healthcare infrastructure development, a shift towards remote
monitoring, and a and a rise in point-of-care testing.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/automated-cell-counter-global-market-report
Scope Of Automated Cell Counter MarketThe Business Research Company's reports
encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Automated Cell Counter Market Overview
Market Drivers -The rising adoption of personalized medicine is expected to
propel the growth of the automated cell counter market going forward.
Personalized medicine refers to tailoring medical treatment to each patient's
individual characteristics, often based on genetic, environmental, and
lifestyle factors. Personalized medicine applications are rising due to
advancements in genetic research and technology, enabling more precise and
effective treatments tailored to individual patient's unique genetic profiles
and health data. Automated cell counting is utilized in personalized medicine
to analyze patient-specific cell populations rapidly and accurately, aiding in
the customization of treatments based on individual cellular profiles. For
instance, in February 2024, according to the Personalized Medicine Coalition
(PMC), a US-based hospital and healthcare company, the FDA approved 16 new
personalized treatments for rare disease patients, a significant increase from
the 6 approved in 2022. Therefore, the rising adoption of personalized medicine
will drive the growth of the automated cell counter market.
Market Trends - Major companies operating in the automated cell counter market
are focusing on the integration of intelligence algorithms and machine learning,
such as the AI automated cell culture system, to optimize and automate the
process of cell growth and scalability in biological research and
biomanufacturing. An AI-automated cell culture system is a technology that
utilizes artificial intelligence to autonomously monitor, manage, and optimize
cell growth and maintenance in laboratory settings. For instance, in October
2023, Molecular Devices LLC, a U.S.-based supplier of analytical systems,
introduced the CellXpress.ai automated cell culture system, an end-to-end,
machine learning-enabled solution that automates demanding feeding and
passaging schedules with an integrated incubator, liquid handler, and imager,
giving scientists more time and autonomy in the lab. The hub incorporates
cutting-edge technology designed to seamlessly oversee the entire cell journey.
It boasts advanced machine learning-powered software that simplifies the
navigation and supervision of complex cell culture processes, complete with
pre-programmed protocols for generating both 2D and 3D models.
The automated cell counter market covered in this report is segmented –
1) By Product: Consumable Accessories, Instruments
2) By Application: Blood Analysis, Urine Analysis, Microbial Cell Count, Cell
Line Viability, Other Applications
3) By End User: Pharmaceuticals And Biotechnology Companies, Hospitals,
Diagnostics Laboratories, Research Institutes, Other End-Users
Get an inside scoop of the automated cell counter market, Request now for
Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15730&type=smp
Regional Insights - North America was the largest region in the automated cell
counter market in 2023. Asia-Pacific is expected to be the fastest-growing
region in the forecast period. The regions covered in the automated cell
counter market report are Asia-Pacific, Western Europe, Eastern Europe, North
America, South America, Middle East and Africa.
Key Companies - Major companies operating in the automated cell counter market
are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd.,
Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies
Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation,
Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories
Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation,
Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc.,
Countstar Inc., Aligned Genetics Inc.
Table of Contents 1. Executive Summary2. Automated Cell Counter Market Report
Structure3. Automated Cell Counter Market Trends And Strategies4. Automated
Cell Counter Market – Macro Economic Scenario5. Automated Cell Counter Market
Size And Growth…..27. Automated Cell Counter Market Competitor Landscape And
Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment